RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2020-321767
Publisher
BMJ
Online
2020-12-25
DOI
10.1136/gutjnl-2020-321767
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis
- (2020) Lei Wu et al. Cancer Immunology Research
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease
- (2019) Amine Majdi et al. JOURNAL OF HEPATOLOGY
- Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells
- (2018) Yingying Jing et al. CANCER LETTERS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Necroptosis microenvironment directs lineage commitment in liver cancer
- (2018) Marco Seehawer et al. NATURE
- Inflammation is independent of steatosis in a murine model of steatohepatitis
- (2017) Wei Wang et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
- (2017) H Chen et al. ONCOGENE
- RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function
- (2017) Kay Hänggi et al. Cell Death & Disease
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury
- (2016) Sanjoy Roychowdhury et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances
- (2016) Jennie Ka Ching Lau et al. JOURNAL OF PATHOLOGY
- The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance
- (2016) Jérémie Gautheron et al. Nature Communications
- Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis
- (2015) Marta B. Afonso et al. CLINICAL SCIENCE
- How cell death shapes cancer
- (2015) V Labi et al. Cell Death & Disease
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
- (2014) J. Gautheron et al. EMBO Molecular Medicine
- Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
- (2014) Huayi Wang et al. MOLECULAR CELL
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
- (2013) Zhenyu Cai et al. NATURE CELL BIOLOGY
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell Proliferation
- (2013) Mihael Vucur et al. Cell Reports
- PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
- (2012) B Shen et al. BRITISH JOURNAL OF CANCER
- Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
- (2012) Feng Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
- (2011) Kris V. Kowdley et al. HEPATOLOGY
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter
- (2010) Irfan J. Lodhi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice
- (2009) Bo Wang et al. HEPATOLOGY
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
- (2009) D.-W. Zhang et al. SCIENCE
- Stearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-γ Responsiveness
- (2008) Aiwei Yao-Borengasser et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started